A detailed history of Global Alpha Capital Management Ltd. transactions in Vericel Corp stock. As of the latest transaction made, Global Alpha Capital Management Ltd. holds 23,383 shares of VCEL stock, worth $1.33 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
23,383
Previous 14,592 60.25%
Holding current value
$1.33 Million
Previous $669,000 47.53%
% of portfolio
0.06%
Previous 0.05%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$42.25 - $53.56 $371,419 - $470,845
8,791 Added 60.25%
23,383 $987,000
Q2 2024

Aug 09, 2024

BUY
$41.71 - $52.9 $608,632 - $771,916
14,592 New
14,592 $669,000

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.67B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Global Alpha Capital Management Ltd. Portfolio

Follow Global Alpha Capital Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Global Alpha Capital Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Global Alpha Capital Management Ltd. with notifications on news.